Chemotherapy group:MFOLFOX6 /FOLFIRI + bevacizumab/cetuximab
Sponsors
Department of Oncology, Affiliated Hospital of Traditional Chinese Medicine, Southwest Medical University
Conditions
colorectal cancer
Early Phase 1
TCM evidence-based capacity building and evidence-based implementation plan of TCM combined with chemotherapy in treatment of metastatic colorectal cancer:A bidirectional cohort study of Zhenqiliujun anti-cancer granules combined with mFOLFOX6/FOLFIRI regimen and bevacizumab/cetuximab in first-line treatment of advanced metastatic colorectal
RecruitingITMCTR2100005329
Start: 2021-04-25Updated: 2023-02-20
TCM evidence-based capacity building and evidence-based implementation plan of TCM combined with chemotherapy in treatment of metastatic colorectal cancer:A bidirectional cohort study of Zhenqiliujun anti-cancer granules combined with mFOLFOX6/FOLFIRI regimen and bevacizumab/cetuximab in first-line treatment of advanced metastatic colorectal
RecruitingChiCTR2100045399
Start: 2021-04-25Updated: 2021-11-22